C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma. - Test2 - elhamkhani - TriplyDB

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

http://www.wikidata.org/entity/Q39178281

about

Clinical impacts of mesothelin expression in gastrointestinal carcinomas Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer.Expression of enoyl coenzyme A hydratase, short chain, 1, in colorectal cancer and its association with clinicopathological characteristics Preoperative serum levels of mesothelin in patients with colon cancer.Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms.ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.Overexpression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivo Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors.Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.

P2860

Q26748680-E2D932AF-5B90-4AC1-BA74-6B7FCAA89DCD Q26778759-7428B014-37C7-41EF-8A37-3356C7E72C95 Q30980266-DB55F26A-B1C4-4CAF-BC88-3386795BD915 Q33820839-1024C0A2-0710-4B2E-89E3-D6788D819339 Q34265767-C3A40731-3FFA-46BF-A59C-4F1EBED64757 Q34588560-7B7DE495-D894-4ED1-9DA4-94B6DEC9B8CE Q35167481-A9F92DDA-5F55-47DC-A89C-6A5DA0636564 Q37404580-1697A831-D8D4-404C-8BC3-741A8C1CE854 Q37688894-88564C20-A117-4FF8-901C-11138ED4FCC6 Q42650659-7E72F172-A4F8-4270-8C0C-5168BD894391 Q53125923-89089520-13CD-4658-8429-3D84A75A1045

P2860

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

http://www.wikidata.org/entity/Q39178281

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@en

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@nl

type

label

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@en

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@nl

prefLabel

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@en

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@nl

P1433

Q39178281-6C724590-2D2C-47D0-A1E1-9CD505EF53D6

P1476

Q39178281-25487307-0B97-4E75-91A8-AF03A94CA9A0

P2093

Q39178281-2C910338-6A62-48DF-B4E9-E273780613BD

Q39178281-3C82A279-A488-4816-9785-5FDF3B26C2BF

Q39178281-62A0B700-8BF5-42AF-A386-1D420EFF9AF5

Q39178281-7138CF1E-88D7-4A90-A0BC-CE06F4DFBDA6

Q39178281-7D8B1485-6350-4F90-B0E3-435981168515

Q39178281-848F2C02-5D1C-420A-AAF2-58C4911B87AF

Q39178281-92E5443F-AA28-4C13-9DE0-4EE6938A0CDD

Q39178281-A7E3CD65-B862-47B3-83A9-A5AA87F7DB13

Q39178281-B0C84E90-052D-4D9D-972D-C9744DCBF600

Q39178281-B619F274-2088-4F17-9425-52CEFD46243E

P2860

Q39178281-04F30808-67E3-4834-8284-40CFAFD5BEF9

Q39178281-0A101ACF-FC84-4D95-B2C4-26CA7DFABB85

Q39178281-0CB7BF0F-B6E5-4218-A093-D8223C7ACB20

Q39178281-2DA4915A-1334-42AC-9D70-9F3E171A6AD3

Q39178281-306466EF-9011-4982-BCD4-72262E1D741B

Q39178281-31990177-4E35-42A7-9E34-18A07BA0B4F4

Q39178281-35E7ECB8-ECAE-4917-8876-0E029D78F596

Q39178281-42B1ECF2-8051-4231-9E20-D4015904399A

Q39178281-4955717C-E30F-434B-900A-DA0DBB8CE8DC

Q39178281-4CFE88A0-1BEB-479B-A9CE-39CF7D5BC16E

P304

Q39178281-A99774AF-AC9F-4459-8D1B-8F5DF0951CF6

P31

Q39178281-307FAF2E-D5A2-4D2E-A628-7FB80FCCA765

P356

Q39178281-D8F6BE6B-ECCA-426D-AEFC-A161CEDE4190

P433

Q39178281-B13CFAEB-B2DC-41C2-A16A-1D7C634C1053

P478

Q39178281-E20267C7-7F2D-4366-A77E-CA6D86A2721B

P577

Q39178281-5285689D-C1D8-4902-BCF7-70CA2BA711CF

P698

Q39178281-96DF817B-00D4-41EE-8B02-46A5A55EFF5B

P921

Q39178281-03E0C899-3182-43E2-AF12-18A1540F8CEA

P356

S00535-013-0773-6

P1433

Journal of Gastroenterology

P1476

C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

@en

P2093

Akinobu Taketomi

http://www.w3.org/2001/XMLSchema#string

Futoshi Kawamata

http://www.w3.org/2001/XMLSchema#string

Hirofumi Kamachi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nishihara

http://www.w3.org/2001/XMLSchema#string

Kazunori Kajino

http://www.w3.org/2001/XMLSchema#string

Masahiro Maeda

http://www.w3.org/2001/XMLSchema#string

Masumi Tsuda

http://www.w3.org/2001/XMLSchema#string

Norihiko Takahashi

http://www.w3.org/2001/XMLSchema#string

Okio Hino

http://www.w3.org/2001/XMLSchema#string

Satoru Todo

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

Cancer statistics, 2012

Mesothelin: a new target for immunotherapy

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

P304

81-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-013-0773-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23512344

http://www.w3.org/2001/XMLSchema#string

P921